Who invested in Antares Therapeutics?
Antares Therapeutics's investors include Lightspeed Venture Partners, Cormorant Asset Management and Omega Funds.

United States · Series A startup
Funding summaryUpdated 26 Oct 2026
$177Mraised across 1 round since 2025, from 1 source
Source recordedSEC filing: $30M sold, first sale May 2025
Antares Therapeutics's investors include Lightspeed Venture Partners, Cormorant Asset Management and Omega Funds.
Antares Therapeutics has raised $177M across 1 round since 2025.
Antares Therapeutics's most recent round was a Series A of $177M in May 2025.
Its most recent round, $177M in May 2025, is also its largest on record.
Antares Therapeutics's first round on record, in May 2025, was backed by Lightspeed Venture Partners, Cormorant Asset Management and Omega Funds.
Antares Therapeutics's latest named round is a Series A, in May 2025.
Antares Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.